SC
Savant Capital Portfolio holdings
AUM
$16.1B
1-Year Return
14.38%
This Quarter Return
+8.8%
1 Year Return
+14.38%
3 Year Return
+48.07%
5 Year Return
+73.78%
10 Year Return
+154.4%
AUM
$16.1B
AUM Growth
+$2.32B
(+17%)
Cap. Flow
+$1.24B
Cap. Flow
% of AUM
7.67%
Top 10 Holdings %
Top 10 Hldgs %
39.16%
Holding
1,981
New
393
Increased
869
Reduced
537
Closed
138
Top Buys
| 1 |
Dimensional US Large Cap Value ETF
DFLV
|
+$115M |
| 2 |
Vanguard Growth ETF
VUG
|
+$88.4M |
| 3 |
Dimensional International High Profitability ETF
DIHP
|
+$87.8M |
| 4 |
Dimensional US Small Cap Value ETF
DFSV
|
+$70.4M |
| 5 |
Vanguard Total Bond Market
BND
|
+$64.8M |
Top Sells
| 1 |
Dimensional US Marketwide Value ETF
DFUV
|
+$24.4M |
| 2 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$15M |
| 3 |
SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$12.6M |
| 4 |
Dimensional US Core Equity 2 ETF
DFAC
|
+$11.1M |
| 5 |
SW
Smurfit Westrock plc
SW
|
+$9.82M |
Sector Composition
| 1 | Technology | 6.06% |
| 2 | Financials | 3.47% |
| 3 | Industrials | 3% |
| 4 | Consumer Discretionary | 2.46% |
| 5 | Healthcare | 2.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IGMS
1826
DELISTED
IGM Biosciences
IGMS
| $22.3K | ﹤0.01% |
19,946
+4,807
| +32% | +$5.38K |
|
1827
Esperion Therapeutics
ESPR
$506M
| $21.5K | ﹤0.01% |
+21,876
| New | +$21.5K |
|
1828
Cassava Sciences
SAVA
$103M
| $20.6K | ﹤0.01% |
+11,397
| New | +$20.6K |
|
1829
Butterfly Network
BFLY
$400M
| $20.1K | ﹤0.01% |
10,050
| – | – |
|
1830
Cabaletta Bio
CABA
$154M
| $19K | ﹤0.01% |
+12,471
| New | +$19K |
|
1831
Baytex Energy
BTE
$1.68B
| $18.7K | ﹤0.01% |
10,446
-6,833
| -40% | -$12.2K |
|
1832
GrafTech
EAF
$229M
| $16.5K | ﹤0.01% |
1,701
-1,243
| -42% | -$12.1K |
|
1833
Ring Energy
REI
$202M
| $14.4K | ﹤0.01% |
18,189
+3,418
| +23% | +$2.71K |
|
1834
Lineage Cell Therapeutics
LCTX
$283M
| $11.7K | ﹤0.01% |
+12,867
| New | +$11.7K |
|
|
URG
1835
Ur-Energy
URG
$529M
| $10.8K | ﹤0.01% |
+10,321
| New | +$10.8K |
|
1836
BARK
BARK
$155M
| $10.5K | ﹤0.01% |
+11,969
| New | +$10.5K |
|
1837
ProKidney
PROK
$292M
| $9.89K | ﹤0.01% |
+16,708
| New | +$9.89K |
|
1838
Century Therapeutics
IPSC
$44.1M
| $8.25K | ﹤0.01% |
+14,769
| New | +$8.25K |
|
1839
Tilray
TLRY
$1.23B
| $7.68K | ﹤0.01% |
18,525
-60,819
| -77% | -$25.2K |
|
1840
FiscalNote
NOTE
$63.9M
| $7.02K | ﹤0.01% |
+1,090
| New | +$7.02K |
|
1841
FibroBiologics
FBLG
$24.1M
| $6.81K | ﹤0.01% |
+10,940
| New | +$6.81K |
|
1842
Mersana Therapeutics
MRSN
$35.1M
| $4.53K | ﹤0.01% |
612
-3,834
| -86% | -$28.4K |
|
1843
TeraWulf
WULF
$3.61B
| – | – |
-48,799
| Closed | -$133K |
|
|
X
1844
DELISTED
US Steel
X
| – | – |
-7,182
| Closed | -$304K |
|
|
VRN
1845
DELISTED
Veren
VRN
| – | – |
-27,513
| Closed | -$182K |
|
|
AIFU
1846
AIFU Inc. Class A Ordinary Share
AIFU
$86.5M
| – | – |
-1,249
| Closed | -$5.25K |
|
|
BERY
1847
DELISTED
Berry Global Group, Inc.
BERY
| – | – |
-27,479
| Closed | -$1.92M |
|
|
ATSG
1848
DELISTED
Air Transport Services Group, Inc.
ATSG
| – | – |
-16,915
| Closed | -$380K |
|
|
ACCD
1849
DELISTED
Accolade, Inc. Common Stock
ACCD
| – | – |
-50,963
| Closed | -$356K |
|
|
NVRO
1850
DELISTED
NEVRO CORP.
NVRO
| – | – |
-15,483
| Closed | -$90.4K |
|